Destruction of AE2 leads to cell alkalization and gastric acid deficiency [97], while AE1/p16 expression leads to the downregulation of AE2, which aggravates cell alkalization and gastric acid deficiency, both of which are characteristics of GC. The gene discussed is SLC4A2; the disease is gastric cancer.